Results 141 to 150 of about 91,310 (286)

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

open access: yesA M A Archives of Ophthalmology, 2002
R. Fechtner   +15 more
semanticscholar   +1 more source

Primary Open-Angle Glaucoma Preferred Practice Pattern®.

open access: yesOphthalmology (Rochester, Minn.), 2020
S. Gedde   +7 more
semanticscholar   +1 more source

Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background and Aims Remimazolam, a new ultra‐short‐acting benzodiazepine, is a safe and effective option for procedural sedation. Nevertheless, to date, no study has directly compared remimazolam and midazolam in diagnostic upper gastrointestinal endoscopy. This study aimed to evaluate the efficacy and safety of remimazolam compared with those
Yehyun Park   +7 more
wiley   +1 more source

Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes. [PDF]

open access: yes, 2016
PurposeThe purpose of this study was to compare retinal nerve fiber layer (RNFL) thickness and optical coherence tomography angiography (OCT-A) retinal vasculature measurements in healthy, glaucoma suspect, and glaucoma patients.MethodsTwo hundred sixty ...
Belghith, Akram   +11 more
core  

The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

open access: yesA M A Archives of Ophthalmology, 2002
M. Gordon   +10 more
semanticscholar   +1 more source

Test–retest variability of the full‐field stimulus test in patients with retinitis pigmentosa: REPEAT Study Report No. 4

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 89-97, February 2026.
Abstract Purpose To evaluate test–retest variability (TRV) of the full‐field stimulus test (FST) in patients with retinitis pigmentosa (RP) and poor best‐corrected visual acuity (BCVA; ≤20/50 Snellen; ≥0.40 logMAR), and to assess the reliability of FST as a clinical endpoint in future RP trials.
J. S. Karuntu   +2 more
wiley   +1 more source

Differences and Similarities Between Primary Open Angle Glaucoma and Primary Angle-Closure Glaucoma

open access: yesEye and Brain
Yiwei Wang,1 Yanzhi Guo,1 Yang Zhang,1 Shouyue Huang,1 Yisheng Zhong1,2 1Author Affiliations Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiao tong University, Shanghai, 200025, People’s Republic of China; 2Author ...
Wang Y, Guo Y, Zhang Y, Huang S, Zhong Y
doaj  

The incidence of serious complications after selective laser trabeculoplasty

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 106-113, February 2026.
Abstract Purpose To evaluate the incidence of serious complications after selective laser trabeculoplasty (SLT). Methods All patients who underwent SLT at the Department of Ophthalmology, Helsinki University Hospital, were eligible for the study from 1 January 2012 to 31 December 2018.
Eeva S. Ojanen   +2 more
wiley   +1 more source

Long‐term outcome of Coats' disease: Implications for the classification of foveal vascular pathologies

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page e104-e111, February 2026.
Abstract Purpose To investigate the long‐term outcome in patients with Coats' disease regarding initial stages. Methods Within a retrospective, clinical, single centre study, patients with diagnosed Coats' disease treated from 1992 to 2019 (minimum follow‐up of 12 months) were investigated. A total of, 75 out of 123 patients met the inclusion criteria.
Claudia Brockmann   +5 more
wiley   +1 more source

Is kidney function associated with primary open-angle glaucoma? Findings from the Asian Eye Epidemiology Consortium

open access: green, 2020
Yih Chung Tham   +22 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy